-
- Igari Kimihiro
- Department of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
-
- Toyofuku Takahiro
- Department of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
-
- Uchiyama Hidetoshi
- Department of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
-
- Koizumi Shinya
- Department of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
-
- Yonekura Koji
- Department of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
-
- Kudo Toshifumi
- Department of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
-
- Jibiki Masatoshi
- Department of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
-
- Sugano Norihide
- Department of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
-
- Inoue Yoshinori
- Department of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
この論文をさがす
抄録
Introduction: Maggots are potent debriding agents capable of removing necrotic tissue and slough; however, it is still unclear which wounds are most likely to benefit from maggot debridement therapy (MDT). Thus, we performed this retrospective review to gain insight into the patient and therapy characteristics influencing outcome.<br>Patients and Methods: We reviewed patients with foot ulcers caused by critical limb ischemia, encountered during the period between June 2005 and May 2010. The treatment outcomes were defined as effective or ineffective.<br>Results: There were 16 patients with 16 leg ulcers. The patients were 13 men and 3 women, with an average age of 67.2 years (range, 47–85 years). Ten (63%) of the 16 ulcers were treated effectively. According to univariate analyses, an ankle brachial pressure index (ABI) lower than 0.6 (p = 0.03) had a negative impact on the outcome of MDT; however, outcome was not influenced by gender, obesity, ischemic heart disease, diabetes mellitus, hemodialysis, smoking, or laboratory findings.<br>Conclusions: Some patient characteristics, such as gender, obesity, ischemic heart disease, diabetes mellitus, hemodialysis, and smoking, do not seem to contraindicate eligibility for MDT. However, a limb with an ABI lower than 0.6 is less likely to benefit. (*English Translation of J Jpn Coll Angiol 2011; 51: 209-213.)
収録刊行物
-
- Annals of Vascular Diseases
-
Annals of Vascular Diseases 6 (2), 145-149, 2013
Annals of Vascular Diseases 編集委員会